Biotechnology Stocks I Performance Guide: Madrigal Pharmaceuticals, Inc. (MDGL)
MDGL has no dividends
Table and Chart of MDGL Performance
See what a $1,000 investment in MDGL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MDGL Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $183.40 |
| End Date | Dec-01-2023 |
| End Price | $213.12 |
| # Prices | 121 |
| Min Date | Jul-29-2016 |
| Min Price | $7.50 |
| Max Date | Apr-28-2023 |
| Max Price | $312.00 |
| Total Return | 16.21% |
| Annualized Return | 1.50% |
| Current Value of $1,000 Purchase | $1,162 |
| Number Returns | 7,260 |
| Average Return | 237.34% |
| Number Profitable Returns | 4,253 |
| Percent Profitable Returns | 58.58% |
| Number Unprofitable Returns | 3,007 |
| Percent Unprofitable Returns | 41.42% |
| Profitable to Unprofitable Returns Ratio | 1.41 |
| MDGL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,207,543,000 | Price to Sales |
| Earnings per Share | $-19.2400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 189.11 |
| PRICE DATA | |
| 52 Week High | $322.67 |
| 52 Week Low | $57.21 |
| Analyst Target Price | $315.92 |
| 50-Day Moving Average | $151.62 |
| 200-Day Moving Average | $216.84 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -21.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MDGL Compare Returns with S&P 500
MDGL Trendline Chart